PT Merck Tbk (IDX:MERK)
Indonesia · Delayed Price · Currency is IDR 4,130.00
+290.00 (7.55%)
Apr 28, 2026, 4:12 PM WIB
PT Merck Tbk Revenue
In the year 2025, PT Merck Tbk had annual revenue of 1.20T IDR with 15.81% growth. PT Merck Tbk had revenue of 386.56B in the quarter ending December 31, 2025, with 36.59% growth.
Revenue
1.20T
Revenue Growth
+15.81%
P/S Ratio
1.54
Revenue / Employee
3.30B
Employees
364
Market Cap
1.85T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20T | 163.92B | 15.81% |
| Dec 31, 2024 | 1.04T | 75.31B | 7.83% |
| Dec 31, 2023 | 961.43B | -163.17B | -14.51% |
| Dec 31, 2022 | 1.12T | 60.20B | 5.66% |
| Dec 31, 2021 | 1.06T | 408.55B | 62.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Kimia Farma Tbk | 9.22T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Prodia Widyahusada Tbk | 2.28T |
| PT Darya-Varia Laboratoria Tbk | 2.12T |
| PT Bundamedik Tbk | 1.61T |